Semaglutide or Tirzepatide: Which GLP-1 Medication Is Right for You?

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider about your specific health needs and treatment options.

By HathawayMD.com Medical Review Team | Updated July 2026

What Are GLP-1 Medications, and How Do They Actually Work?

Your body naturally produces a hormone called GLP-1 (glucagon-like peptide 1). Think of this hormone as your brain's “I'm full” messenger. When you eat, your gut releases GLP-1, which travels to your brain and says, “Hey, you've had enough food. Stop eating now.”

For people struggling with weight, this system doesn't always work well. Either the body doesn't make enough GLP-1, or the brain doesn't hear the message clearly. This is where medications like semaglutide and tirzepatide step in.

These medications are “GLP-1 agonists” (meaning they copy or mimic what GLP-1 does). When you take them, they act like an amplified version of your natural hormone. They tell your brain you're full faster and keep you feeling satisfied longer. They also slow how quickly your stomach empties, so food stays in your digestive system longer. This combination makes you eat less without consciously fighting hunger.

You inject these medications once a week under your skin (like an insulin shot, but much easier). The medication stays in your system for about a week, then you give yourself another injection.

Semaglutide: The Single-Action Option

How It Works

Semaglutide is a GLP-1 receptor agonist (it only targets the GLP-1 hormone pathway). It's been FDA-approved for weight loss since 2021 under the brand name Wegovy. You may have also heard of Ozempic, which is the same medication but approved for diabetes at lower doses.

Key facts about semaglutide:

• Been on the market longer than tirzepatide
• Has the most insurance coverage and established track record
• Available in doses from 0.25 mg up to 2.4 mg per week
• Takes about 8-16 weeks to reach the full effective dose (doctors start low and increase gradually)

Weight Loss Results

In the STEP clinical trials (where researchers test if a medication actually works), people taking semaglutide at the highest dose lost an average of 17.3% of their body weight over 68 weeks. That means someone who weighed 200 pounds might lose about 35 pounds.

This is a real, significant difference. But there's more: some people in the studies lost more, and some lost less. Individual results vary a lot.

Tirzepatide: The Dual-Action Option

How It Works

Tirzepatide is newer. It's a “dual GLP-1/GIP receptor agonist” — which is fancy doctor-speak for “it targets two hormone pathways instead of just one.”

Here's the key difference: Tirzepatide copies both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), another hormone your gut makes. Think of it like buying a two-in-one shampoo and conditioner instead of using shampoo alone. The GIP part adds extra weight-loss power.

Key facts about tirzepatide:

• FDA-approved for weight loss in 2023 under the brand name Zepbound
• Also approved for diabetes under the name Mounjaro
• Available in doses from 2.5 mg up to 15 mg per week
• Also requires a gradual dose increase over several weeks

Weight Loss Results

In the SURMOUNT clinical trials, people taking tirzepatide at the highest dose lost an average of 22.5% of their body weight. That's the same 200-pound person losing about 45 pounds — nearly 10 pounds more than with semaglutide on average.

The bottom line: In head-to-head comparison, tirzepatide showed higher average weight loss. But this doesn't mean it's “better” for everyone — some people respond better to one than the other.

Side-by-Side Comparison Table

Side Effects: Are They Different?

Both medications can cause similar side effects because they work through related pathways in your body. The most common ones are:

• Nausea — the most frequent complaint (usually mild to moderate)
• Constipation — slower digestion means slower bathroom trips
• Diarrhea — some people experience this instead of constipation
• Vomiting — less common, usually when people increase doses too quickly
• Fatigue — some people feel more tired, especially early on

The real difference? Individual people experience these side effects differently. Some people on semaglutide have barely any nausea, while others feel quite sick. The same is true for tirzepatide. There's no way to predict exactly how your body will respond until you try it.

The side effects usually improve over time as your body adjusts. Most people report that nausea decreases after a few weeks at the same dose.

Cost and Insurance Coverage

What Does This Cost?

Without insurance, expect to pay about $900 to $1,500 per month for either medication. That's roughly $11,000 to $18,000 per year. These are expensive medications.

With insurance: Your co-pay depends entirely on your plan. Some insurance companies cover these medications fully or with a small co-pay. Others don't cover them for weight loss at all (they may cover them for diabetes). Call your insurance company directly to ask.

Coverage Trends

Semaglutide has been around longer, so more insurance plans currently cover it. Tirzepatide is newer, and coverage is expanding but still not universal. This is one reason many doctors prescribe semaglutide first — it's more likely to be covered.

Some pharmaceutical companies offer patient assistance programs if you can't afford the medication. Talk to your doctor or call the manufacturer directly.

Which One Do Doctors Usually Prescribe First?

Most doctors start with semaglutide. Here's why:

• It's been available longer (since 2021 vs 2023)
• Doctors have more experience with it
• Insurance coverage is more predictable
• Both medications work, and semaglutide has a longer track record

That said, if semaglutide isn't working well for you after several months, or if you have intolerable side effects, your doctor may switch you to tirzepatide. Some doctors also start with tirzepatide if they think you need the “stronger” option upfront.

There's no universal “right choice.” It depends on your insurance, your doctor's experience, your specific health situation, and how your body responds to the first medication you try.

How Long Do You Need to Take These Medications?

Here's the honest answer: You need to take them as long as you want to keep the weight off.

These medications are not a cure. They're a tool that helps you eat less while you're using them. Once you stop taking them, your hunger hormones go back to normal. Your appetite returns. For most people, the weight gradually comes back.

This is really important to understand: Studies show that about 50% of weight loss returns within 1-2 years after stopping the medication. Some people maintain better than others, especially if they've made permanent changes to their eating habits and exercise routines.

Think of it like blood pressure medication. If you have high blood pressure and take medication to control it, you usually need to keep taking it. Your blood pressure doesn't stay down just because you took the pills for a year — you need ongoing treatment. These weight-loss medications work the same way.

What Happens When You Stop?

If you decide to stop taking semaglutide or tirzepatide, here's what typically happens:

• Hunger returns gradually. Your appetite and fullness signals go back to how they were before treatment, usually over a few weeks.
• Weight may come back. Most people regain some weight, though not always all of it.
• The timeline varies. Some people maintain their new weight for months, while others start regaining within weeks.
• Lifestyle habits matter. If you've genuinely changed your eating and exercise habits during treatment, you're more likely to keep the weight off.

You should talk with your doctor before stopping. Don't just quit cold turkey. Your doctor can help you plan how to maintain your progress and discuss whether continuing the medication makes sense for your health and finances.

Emerging Applications

While semaglutide and tirzepatide are primarily prescribed for weight management and diabetes, new research is exploring unexpected uses. A University of Colorado trial found that oral semaglutide may help reduce heavy drinking in people with alcohol use disorder — a finding that could reshape how clinicians think about GLP-1 medications.

The Bottom Line: Which Should You Choose?

There is no universal winner. Both medications work. Tirzepatide shows slightly higher average weight loss, but this doesn't mean it's better for you specifically.

Here's what matters:

• What your insurance will cover
• What your doctor recommends based on your health history
• How your individual body responds to the medication
• Whether you can tolerate the side effects
• Whether you're ready to commit to ongoing treatment

Start the conversation with your doctor. Tell them about your weight loss goals, any health conditions you have, medications you take, and your concerns about cost and side effects. They can help you decide which medication is right for you.

If the first one doesn't work well, you can usually try the other. Treatment is not a permanent decision — you and your doctor can adjust your approach as you go.

---

This article is for informational purposes only and does not constitute medical advice. The information presented reflects clinical trial data and FDA-approved uses as of July 2026. Weight loss results, side effects, costs, and insurance coverage can vary significantly based on individual factors and geographic location. Always consult with a qualified healthcare provider before starting any new medication. Your doctor can assess your personal health needs, review potential drug interactions, and help you make the best choice for your specific situation.

Disclaimer: This content is for informational and educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any medication or treatment program. The information provided here has not been evaluated by the Food and Drug Administration (FDA). Individual results may vary. This site may contain affiliate links — see our editorial standards for details.